Elequin Capital’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-50
Closed -$2.08K 549
2023
Q2
$2.08K Buy
+50
New +$2.08K ﹤0.01% 442
2023
Q1
Sell
-52
Closed -$3.81K 468
2022
Q4
$3.81K Sell
52
-23
-31% -$1.69K ﹤0.01% 550
2022
Q3
$6K Sell
75
-61
-45% -$4.88K ﹤0.01% 311
2022
Q2
$9K Buy
136
+36
+36% +$2.38K ﹤0.01% 248
2022
Q1
$8K Buy
+100
New +$8K ﹤0.01% 182